Although a lack of evidence exists for increased Gd‐IgA1 in COVID‐19‐related IgAV, an increase in anti‐cardiolipin and anti‐β2GPI IgA has been identified in severe COVID‐19 cases.98 This evidence concerns the gene IGHA1 and COVID-19.